Alcyone Lifesciences, Inc. — Form D/A

Alcyone Lifesciences, Inc. of LOWELL, MA, a company, filed a Form D amendment with the SEC on 2025-01-08. The offering totals $31.6M, of which $19.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
PJ AnandDirectorLowell, MA
David DonabedianDirectorLowell, MA
Cameron DurrantDirectorLowell, MA
Edgar D JannottaDirectorLowell, MA
Stephen D OesterleDirectorSCOTTSDALE, AZ
Norbert D RiedelDirectorLowell, MA
Richard UptonDirectorLowell, MA
PJ AnandExecutive OfficerLowell, MA
David DonabedianRelated PersonLowell, MA
Cameron DurrantRelated PersonLowell, MA
Richard UptonRelated PersonLowell, MA
PJ AnandRelated PersonLowell, MA
Edgar D Jannotta, Jr.DirectorWestport, CT
Piratip PratumsuwanDirectorLOWELL, MA
Edgar Jannotta, Jr.DirectorLowell, MA
Edgar Jannotta, Jr.Related PersonLowell, MA
Stephen OesterleDirectorLowell, MA
Stephen OesterleRelated PersonLowell, MA
Edgard Jannotta, Jr.DirectorConcord, MA

Other filings by this issuer (10)

FiledFormOfferingSold
2023-11-22D$31.6M$17.3M
2021-06-17D$37.1M$37.1M
2020-09-02D$19.5M$17.6M
2019-07-03D$3.0M$2.2M
2019-04-11D$1.6M$1.6M
2018-01-17D$5.1M$5.1M
2015-12-24D$3.7M$3.6M
2014-01-13D$4.0M$4.0M
2013-05-20D$1.0M$1.0M
2012-03-27D$2.0M$1.8M

More